Koninklijke Philips | PHG - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Demant DKK 9.63B 241M 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Fresenius EUR 5.25B 337M 2025-12
General Electric Aerospace USD 18.06B 7.11B 2026-03
Getinge SEK 9.99B 2.3B 2024-12
Globus Medical USD 595.85M 49.26M 2026-03
GN Store Nord DKK 2.16B 1.94B 2026-03
Hitachi JPY 2.71T 314.71B 2026-03
Idexx Laboratories USD 778.23M 3.26M 2026-03
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Koninklijke Philips EUR 5.1B 597.33M 2025-12
Masimo USD 326.2M 2.4M 2026-03
Medtronic USD 7.72B 436M 2026-03
Philips EUR 3.6B 775M 2026-03
ResMed USD 925.74M 525K 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Steris USD 1.27B 51.5M 2026-03
Stryker USD 4.92B 284M 2026-03
Teleflex USD 3.08B 2.55B 2026-03
Terumo JPY 268.87B 16.12B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03